Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CCR3 | P51677 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.52 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.51 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.51 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.51 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21650862 | 0.93 | NPC1 (0.63) | HRH3ALDH1A1CCR3NPC1RAB9A | |
| SCHEMBL19227711 | 0.90 | HRH3 (0.81) | HRH3ALDH1A1TSHRMBTD1L3MBTL3 | |
| SCHEMBL25137036 | 0.87 | HRH3 (0.62) | HRH3ALDH1A1TSHRNPC1RAB9A | |
| SCHEMBL11199523 | 0.87 | HRH3 (0.58) | HRH3TSHR | |
| SCHEMBL8218978 | 0.86 | HRH3 (0.56) | HRH3ALDH1A1CCR3TSHRNPC1 | |
| SCHEMBL14142451 | 0.86 | CXCR4 (0.60) | HRH3TSHR | |
| SCHEMBL18753872 | 0.86 | HRH3 (0.53) | HRH3ALDH1A1CCR3NPC1RAB9A | |
| SCHEMBL2091907 | 0.83 | HRH3 (0.67) | HRH3ALDH1A1CCR3TSHRNPC1 | |
| SCHEMBL13061368 | 0.80 | LMNA (0.65) | HRH3ALDH1A1NPC1RAB9ATP53 | |
| SCHEMBL28144854 | 0.80 | HRH3 (0.47) | HRH3ALDH1A1TSHRNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017706-B2 | Process for production of polymers with iron complex catalyst | DIC CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporatio (JP) | 2011-05-05 | — | — | US | disclosed |
| EP-2269995-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | TFRC, FECH, FTH1 | HRH3 1774/4885ALDH1A1 4106/4885CCR3 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.